 |
A newsletter for those involved in clinical trials. Published 20 times a
year by Canary LtdEthical issues
The following articles on this topic have been published in
CRAdvisor (CRA) – the year, issue number
and starting page number for each are listed below:
Back to index |
| 2006 |
|
|
CRA 2006; 170:7 |
Best practice in research conduct. |
|
CRA 2006; 171:7 |
Initiative to promote best practice in UK research. |
|
CRA 2006; 182:2 |
Revised ethics guidance for trials in children. |
|
CRA 2006; 182:11 |
Consumers for Ethics in Research to disband this month. |
|
CRA 2006; 182:11 |
End-of-life care. |
| |
|
| 2005 |
|
| CRA 2005; 147:6 |
NIH announces ethics reform. |
| CRA 2005; 154:4 |
2001/20/EC: procedures in Belgium. |
| CRA 2005; 157:6 |
US National Institutes of Health issues final ethics rule. |
| |
|
| 2003 |
|
| CRA 2003: 102:1 |
WHO updates international ethical guidelines for clinical studies. |
| CRA 2003; 103:3 |
Ethics and research in developing countries. |
| CRA 2003; 120:4 |
WHO's contributions to research ethics. |
| |
|
| 2002 |
|
| CRA 2002; 82:7 |
UK national anti-fraud body proposed. |
| CRA 2002; 84:2 |
WHO expresses concerns on publication practices. |
| CRA 2002; 89:1 |
Guidance for genetic investigation. |
| CRA 2002; 90:6 |
New draft of CIOMS bioethics guidelines expected soon. |
| |
|
| 2001 |
|
| CRA 2001; 61:5 |
Ethical considerations in HIV preventative research. |
| CRA 2001; 63:1 |
Horrific extent of organ research revealed. |
| CRA 2001; 63:4 |
Patient Protection Procedures to be revised. |
| CRA 2001; 64:4 |
International trials - are they performed ethically? |
| CRA 2001; 66:1 |
Australians used as guinea-pigs for global drug market". |
| CRA 2001; 67:3 |
Early termination of studies may harm subjects. |
| CRA 2001; 71:6 |
CIOMS issues new ethics guidance. |
| CRA 2001; 74:6 |
Journals to demand author's independence. |
| CRA 2001; 77:6 |
Pharmaceutical funding for AMA. |
| CRA 2001; 78:6 |
Research fraud observed by consultants. |
| CRA 2001; 80:8 |
National award program to promote subject protection. |
| |
|
| 2000 |
|
| CRA 2000; 41:5 |
US guidance for research in mental disorders. |
| CRA 2000; 42:5 |
Stopping clinical trials is unethical. |
| CRA 2000; 42:6 |
Post-patient trial meeting? |
| CRA 2000; 44:3 |
Do volunteers know the consequences of secret trials? |
| CRA 2000; 44:4 |
Survey of ethical misconduct perceptions. |
| CRA 2000; 47:4 |
“Human beings as guinea pigs.” |
| CRA 2000; 48:1 |
UK Government to ‘save’ clinical trials. |
| CRA 2000; 50:4 |
Ethics Committees and protocol amendments. |
| CRA 2000; 55:3 |
Financial disclosure and conflicts of interest. |
| CRA 2000; 56:3 |
Use of placebo still major cause of ethical unrest. |
| CRA 2000; 56:4 |
Inappropriate patient recruitment procedures. |
| CRA 2000; 59:1 |
Investigator need may jeopardise trial subject safety. |
| |
|
| 1999 |
|
| CRA 1999; 20:6 |
Will Ethics Committees cap the recruitment time? |
| CRA 1999; 23:4 |
When is a protocol amendment an administrative change? |
| CRA 1999; 24:6 |
Financial arrangement with investigator not subject to Ethics Committee scrutiny. |
| CRA 1999; 25:1 |
Why not pay patients who take part in trials? |
| CRA 1999; 32:5 |
Making the healthy sick for trials. |
| |
|
| 1998 |
|
| CRA 1998; 3:1 |
Justifying the use of placebo: regulations versus ethics. |
| CRA 1998; 3:3 |
Ethical principles and the use of placebo. |
| CRA 1998; 10:1 |
All risks or just some risks? |
| CRA 1998; 18:5
| When is a protocol amendment an administrative change? |